Claes Wahlestedt
Affiliations: | Neuroscience | Scripps Florida, Jupiter, FL, United States |
Google:
"Claes Wahlestedt"Mean distance: 42746.4
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dennison JL, Al-Ali H, Volmar CH, et al. (2022) Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers. 14 |
| Kemper C, Benham D, Brothers S, et al. (2022) Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL ). Aaps Open. 8: 11 |
| Dennison JL, Volmar CH, Modarresi F, et al. (2022) Erratum to: JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model. Journal of Alzheimer's Disease : Jad |
| Dennison JL, Volmar CH, Ke D, et al. (2022) JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model. Journal of Alzheimer's Disease : Jad |
| Khalafi S, Zhu S, Khurana R, et al. (2022) A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. Translational Oncology. 15: 101260 |
| Kuznetsoff JN, Owens DA, Lopez A, et al. (2020) Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal melanoma. Molecular Cancer Research : McR |
| Lohse I, Azzam DJ, Al-Ali H, et al. (2019) Ovarian Cancer Treatment Stratification Using Drug Sensitivity Testing. Anticancer Research. 39: 4023-4030 |
| Mustafi S, Camarena V, Qureshi R, et al. (2019) Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer. Ebiomedicine |
| Bagheri A, Habibzadeh P, Razavipour SF, et al. (2019) HDAC Inhibitors Induce Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons. International Journal of Molecular Sciences. 20 |
| Copsel SN, Lightbourn CO, Barreras H, et al. (2018) BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. Frontiers in Immunology. 9: 3104 |